23 September, 2008
Bookmark and Share
Dean Agrawal Appointed to Emerging Technology Fund
Texas Governor Rick Perry has appointed Dr. C. Mauli Agrawal, Dean, College of Engineering at the University of Texas at San Antonio (UTSA), to the Emerging Technology Fund (ETF) Advisory Committee. This committee recommends projects to be considered for funding from the ETF to the governor, lieutenant governor and speaker of the house.
The ETF is a $200 million initiative established by the Texas legislature to attract top researchers and scientists to Texas and to support technology-based start-up companies. To date the ETF has awarded more than $110 million.
Dr. Agrawal has authored more than 265 scientific publications and his work has resulted in several patents, which have been licensed to commercial entities. He is also a founder of Xilas Medical, Inc. (now Diabetica Solutions), a San Antonio based medical device company working in the area of diabetic foot problems. Xilas was selected as the first company in Texas to be funded by the Governor’s Emerging Technology Fund in 2006. Most recently Dr. Agrawal has co-founded companies with the goal of taking new technologies for drug eluting cardiovascular stents and bone repair to market. In 2007, he was awarded the Chancellor’s Entrepreneurship and Innovation Award from the University of Texas System, and the Healthcare Hero Award for biomedical research by the San Antonio Business Journal.

Dean Agrawal Appointed to Emerging Technology Fund

Texas Governor Rick Perry has appointed Dr. C. Mauli Agrawal, Dean, College of Engineering at the University of Texas at San Antonio (UTSA), to the Emerging Technology Fund (ETF) Advisory Committee. This committee recommends projects to be considered for funding from the ETF to the governor, lieutenant governor and speaker of the house.

The ETF is a $200 million initiative established by the Texas legislature to attract top researchers and scientists to Texas and to support technology-based start-up companies. To date the ETF has awarded more than $110 million.

Dr. Agrawal has authored more than 265 scientific publications and his work has resulted in several patents, which have been licensed to commercial entities. He is also a founder of Xilas Medical, Inc. (now Diabetica Solutions), a San Antonio based medical device company working in the area of diabetic foot problems. Xilas was selected as the first company in Texas to be funded by the Governor’s Emerging Technology Fund in 2006. Most recently Dr. Agrawal has co-founded companies with the goal of taking new technologies for drug eluting cardiovascular stents and bone repair to market. In 2007, he was awarded the Chancellor’s Entrepreneurship and Innovation Award from the University of Texas System, and the Healthcare Hero Award for biomedical research by the San Antonio Business Journal.